[1] Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet, 2012; 380, 601−10. doi:  10.1016/S0140-6736(12)60987-8
[2] Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA, 2003; 289, 2560−72. doi:  10.1001/jama.289.19.2560
[3] Wang YF, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med, 2004; 164, 2126−34. doi:  10.1001/archinte.164.19.2126
[4] Gu DF, Reynolds K, Wu XG, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 2002; 40, 920−7. doi:  10.1161/01.HYP.0000040263.94619.D5
[5] Mullican DR, Lorenzo C, Haffner SM. Is prehypertension a risk factor for the development of type 2 diabetes? Diabetes Care, 2009; 32, 1870−2. doi:  10.2337/dc09-0328
[6] Gress TW, Nieto FJ, Shahar E, et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study. N Engl J Med, 2000; 342, 905−12. doi:  10.1056/NEJM200003303421301
[7] Genuth S, Alberti KGMM, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 2003; 26, 3160−7. doi:  10.2337/diacare.26.11.3160
[8] Zhang KX, Zhao Q, Li Y, et al. Feasibility of anthropometric indices to identify dyslipidemia among adults in Jilin Province: a cross-sectional study. Lipids Health Dis, 2018; 17, 16. doi:  10.1186/s12944-017-0648-6
[9] Newsholme P, Homem De Bittencourt PI Jr, O’ Hagan C, et al. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. Clin Sci (Lond), 2010; 118, 341−9. doi:  10.1042/CS20090433